Regeneron Pharmaceuticals, Inc. (REGN)
828.50
-5.54
(-0.66%)
USD |
NASDAQ |
Aug 24, 16:00
830.00
+1.50
(+0.18%)
After-Hours: 04:41
Regeneron Pharmaceuticals Total Return Level : 836.18 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 836.18 |
| August 21, 2026 | 841.77 |
| August 20, 2026 | 834.30 |
| August 19, 2026 | 848.64 |
| August 18, 2026 | 817.75 |
| August 17, 2026 | 812.46 |
| August 14, 2026 | 809.99 |
| August 13, 2026 | 812.50 |
| August 12, 2026 | 804.46 |
| August 11, 2026 | 803.46 |
| August 10, 2026 | 814.60 |
| August 07, 2026 | 790.72 |
| August 06, 2026 | 778.37 |
| August 05, 2026 | 774.81 |
| August 04, 2026 | 766.82 |
| August 03, 2026 | 765.39 |
| July 31, 2026 | 768.81 |
| July 30, 2026 | 744.32 |
| July 29, 2026 | 701.05 |
| July 28, 2026 | 700.81 |
| July 27, 2026 | 672.58 |
| July 24, 2026 | 661.33 |
| July 23, 2026 | 657.19 |
| July 22, 2026 | 656.46 |
| July 21, 2026 | 680.66 |
| Date | Value |
|---|---|
| July 20, 2026 | 677.60 |
| July 17, 2026 | 682.17 |
| July 16, 2026 | 684.44 |
| July 15, 2026 | 669.83 |
| July 14, 2026 | 661.44 |
| July 13, 2026 | 668.46 |
| July 10, 2026 | 669.90 |
| July 09, 2026 | 673.36 |
| July 08, 2026 | 668.25 |
| July 07, 2026 | 681.71 |
| July 06, 2026 | 655.08 |
| July 02, 2026 | 659.57 |
| July 01, 2026 | 629.78 |
| June 30, 2026 | 628.59 |
| June 29, 2026 | 636.93 |
| June 26, 2026 | 638.03 |
| June 25, 2026 | 625.16 |
| June 24, 2026 | 628.48 |
| June 23, 2026 | 623.04 |
| June 22, 2026 | 617.46 |
| June 18, 2026 | 614.88 |
| June 17, 2026 | 612.86 |
| June 16, 2026 | 619.71 |
| June 15, 2026 | 619.96 |
| June 12, 2026 | 617.10 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Alnylam Pharmaceuticals, Inc. | 236.01 |
| Gilead Sciences, Inc. | 213.86 |
| AbbVie, Inc. | 455.64 |
| Vertex Pharmaceuticals, Inc. | 547.59 |
| Amgen, Inc. | 664.62 |